[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"turbt\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:turbt":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":4},"100623392","intraoperative-bladder-injury-assessment-in-turbt-using-bicep-100623392",false,"NCT07396038","INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP","Evaluation of Intraoperative Bladder Injuries During Transurethral Resection of Bladder Tumors Using the BICEP Classification (BICEP on TURBT)","BICEP in TURBT","Inclusion Criteria:\n\n* Adult patients aged 18 years or older\n* Patients undergoing transurethral resection of bladder tumor\n* Procedures performed for primary resection, re-resection, diagnostic, or staging purposes\n\nExclusion Criteria:\n\n* Patients with incomplete intraoperative data regarding bladder injury assessment\n* Patients who decline participation, if informed consent is required","ALL","18 Years",{"count":20,"type":21},1000,"ESTIMATED","12 Months","OBSERVATIONAL","Transurethral resection of bladder tumor (TURBT) is the cornerstone procedure in the diagnosis and treatment of bladder cancer but is associated with a spectrum of intraoperative bladder injuries ranging from minor mucosal tears to major perforations. Currently, there is no standardized intraoperative classification system specifically designed to grade and report these injuries during TURBT.\n\nThis study aims to apply the Bladder Injury Classification System for Endoscopic Procedures (BICEP) to TURBT in order to systematically classify intraoperative bladder injuries, evaluate their management, and explore their association with perioperative and early postoperative outcomes.",[26,27,28],"Bladder (Urothelial, Transitional Cell) Cancer","TURBT","Bladder Injury",[30,31,32,33,34,35],"Transurethral resection of bladder tumor","Bladder perforation","Bladder cancer surgery","Bladder injury classification","Ureteral orifice injury","Endoscopic bladder surgery complications","NOT_YET_RECRUITING","2026-02-05",{"date":39,"type":40},"2026-02-09","ACTUAL",{"date":42,"type":21},"2026-02-15",{"date":44,"type":21},"2027-03-30",{"name":46,"class":47},"Necmettin Erbakan University","OTHER",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":68,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":82},"100591612","anesthesia-modality-and-oncologic-outcomes-in-high-risk-nmibc-a-randomized-trial-100591612","NCT06982690","Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial","Impact of Anesthesia Modality on Recurrence and Progression in High-Risk Non-Muscle Invasive Bladder Cancer: A Randomized Controlled Trial Comparing Spinal Versus General Anesthesia","Inclusion Criteria:\n\n* Age ≥40 years for male subjects or postmenopausal female subjects\n* ECOG performance status 0-2\n* Patients with suspected or newly diagnosed UBUC\n* ASA I or II\n* Patients with any other adequately treated Stage I or II cancer except UC, from which the subject has been disease free for 5 years\n* Adequate renal function, defined as a serum creatinine (Cre) concentration ≤ the institutional ULN\n* Adequate hepatic function, defined as total bilirubin ≤ the institutional ULN and alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ the institutional upper limit of normal (ULN)\n\nExclusion Criteria:\n\n* Patients with prior or concurrent UC involving the renal pelvis, ureter or urethra\n* Patients with clinical evidence of MIBC or mUC\n* Immunocompromised or immunosuppressed patients\n* Patients with chronic use of anti-inflammatory agents or beta-blockers\n* Patients with difficult airways or other significant cardiovascular comorbidities (severe aortic stenosis, significant pulmonary disease, CHF) who are intolerant to GA\n* Patients with elevated intracranial pressure (ICP), primarily due to intracranial mass and trauma or infection at the site of SA\n* Patients with a serious uncontrolled medical disorder (e.g., trauma, fracture) or active infection that would impair their ability to receive spinal or GA\n* Patients with known allergies to propofol, fentanyl, sevoflurane, or bupivacaine\n* Subjects with a known history or family history of malignant hyperthermia\n* Subjects with bleeding diathesis","20 Years","80 Years",{"count":58,"type":21},370,"INTERVENTIONAL",[61],"NA","To demonstrate the superior efficacy of spinal anesthesia (SA) versus general anesthesia (GA) according to the delay of time to recurrence in high-risk NMIBC patients up to Week 104 after TURBT.",[64,27,26,65,66,67],"NMIBC","Bladder Cancer Recurrence","Anesthesia, General","Anesthesia,Spinal",[69,70,71,72,27],"bladder cancer","general anesthesia","spinal anesthesia","recurrence","2025-05-13",{"date":75,"type":40},"2025-05-21",{"date":77,"type":21},"2025-08-01",{"date":79,"type":21},"2029-11-30",{"name":81,"class":47},"National Taiwan University Hospital",1]